Back to results
US 2020/0048646 A1Published application
Gene editing and transgene free mutant plants
AssigneeThe Regents of the University of California
InventorYunde Zhao
Life of this patent
Estimating the term…
Abstract
The disclosure provides compositions and methods to transform and edit the genome of plants and to measure heritable genetic modifications.
Claims25
A recombinant engineered, non-naturally occurring gene editing system comprising one or more vectors comprising:
- (a) at least one first regulatory element operable in a plant cell and operably linked to at least one nucleotide sequence encoding a CRISPR-Cas system guide RNA (gRNA) for targeting a target sequence in a plant,
- (b) a second regulatory element operable in a plant cell operably linked to a nucleotide sequence encoding a class 2 CRISPR-associated nuclease, and
- (c) a third regulatory element operable in a plant cell operably linked to a fluorescent reporter and
- optionally (d) a fourth regulatory element linked to an antibiotic resistance gene,
- wherein component (a) is located on the same or different vector than components (b) and (c), whereby the guide RNA targets the target sequence and the CRISPR-associated nuclease cleaves the DNA molecule, whereby expression of the at least one gene product is altered;
- and, wherein the CRISPR-associated nuclease and the guide RNA do not naturally occur together.
3 more elements
Dependencies are inferred from the claim text.